Novartis Plans June Launch For Paget’s Disease Therapy Reclast

FDA action on NDA for postmenopausal osteoporosis indication expected in the second half.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet